Suppression of Adjuvant Arthritis in Rats with Chronic Bromocriptine Treatment Does not Prevent Associated Oxidative Stress

Abstract

We studied the effect of prolactin (PRL) inhibition by bromocriptine (BRC) in the first phase of adjuvant induced arthritis (AA), up to day 11 (BRC1-AA), and in the whole time course of AA, up to day 23 (BRC-AA), on the development of the disease in male Lewis rats. On day 24, arthritic rats showed inhibition of PRL secretion, but not PRL mRNA expression in adenopituitaries. BRC treatment suppressed PRL serum levels and PRL mRNA expression in adenopituitaries. In BRC1-AA group PRL levels and PRLmRNA were at the level of rats with AA. Serum corticosterone (CORT) was stimulated by AA from 16.9±5.8 to 59.1±8.7 ngml⁻¹, p<0.05, to the same level in BRC-control (BRC-C) and BRC-AA group and further potentiated in BRC1-AA group (148.2<33.1 ngmr⁻¹, p<0.05 vs. group with AA). Hind paw swelling was reduced but not completely inhibited in BRC1-AA group and totally prevented in BRC-AA rats as was the core temperature (36.5<0.1°C vs. 37.4<.0.1 °C in AA rats on day 23, p<0.01). Serum concentration of NO-₂/NO⁻₃ rose in rats with AA to 28.7±2.5 μmolL⁻¹ against. 13.9±1.9 μmolL⁻¹ in controls (p<0.01), remained elevated in BRC-AA group and was potentiated in BRC1-AA group (48.2±3.5 μmolL⁻¹, p<0.01 vs. AA or BRC1-AA group) Thiobarbituric acid reactive substances (TBARS) and antioxidant capacity in the spleen were enhanced in rats with AA and to the same extent in BRC-AA or BRC1-AA groups. These results show a discrepancy between the suppression of clinical symptoms and persisting oxidative stress in AA rats after the BRC induced PRL inhibition. The potentiation of nintric oxide (NO) production after the sudden cessation of PRL inhibition during the disease may promote further joint damage.

Keywords

Rat adjuvant arthritis bromocriptine nitric oxide oxidative stress

References

Mapp

P.I.

Grootveld

M.C.

and Blake

D.R.

. 1995. Hypoxia, oxidative stress and rheumatoid arthritis. British Med. Bull. 51:419.

Murell

G.A.

Jang

and Williams

R.J.

. 1995. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun. 206:15.

Stefanovic-Racic

Meyers

Meschter

Coffey

J.W.

Hoffman

R.A.

and Evans

C.H.

. 1994. N-monomethy 1 arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum. 37:1062.

Clevenger

C.V.

Sillman

A.L.

Hanley-Hyde

and Prystowsky

M.B.

. 1992. Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology 130:3216.

Rovensky

Buc

Lojda

Ruzickova

Blazickova

Rauova

L'.

Mistina

Vigas

and Lackovic

. 1995. Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women. Arch. Immunol. Ther. Exp. (Warsz.) 43:221.

Chuang

T.T.

Caccavelli

Cordon

, and Enjalbert

. 1983. Protein kinase C regulation of prolactin gene expression in lactotroph cells: Involvement in dopamine inhibition. Endocrinology 132:832.

Nagy

Berczi

Wren

G.E.

Asa

S.L.

and Kovacs

. 1983. Immunomodulation by bromocriptine. Immunopharmacology 6:231.

Berczi

Nagy

Asa

S.L.

and Kovacs

. 1984. The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum. 27:682.

Whyte

and Williams

R.O.

. 1988. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum. 31:927.

10.

Eulry

Mayaudon

Lechevalier

Bauduceau

Ariche

Ouakil

Crozes

and Magnin

. 1995. Treatment of rheumatoid psoriasis with bromocriptine. Presse Med. 24:1642.

11.

Figueroa

F.E.

Carrion

Martinez

M.E.

Rivero

and Mamani

. 1997. Bromocriptine induces immunological changes related to disease parameters in rheumatoid arthritis. Br. J. Rheumatol. 36:1022.

12.

Lowry

O.H.

Rosenbrough

N.J.

Farr

A.L.

, and Randall

R.J.

. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265.

13.

Cortas

N.K.

and Wakid

N.W.

1990. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36:1440.

14.

Neidhardt

and Fluckiger

E.W.

. 1992. Hyperprolactinemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 77:449.

15.

Neidhardt

and Larson

D.F.

. 1990. Freund's complete adjuvant induces ornithine decarboxylase activity in the central nervous system of male rats and triggers the release of pituitary hormones. J. Neuroimmunol. 26:97.

16.

Selgas

Arce

Esquilino

A.I.

and Cardinali

D.P.

. 1997. Twenty-four-hour rhythms of serum ACTH, prolactin, growth hormone, and thyroid-stimulating hormone, and of median-eminence norepinephrine, dopamine, and serotonin, in rats injected with Freund's adjuvant. Chronobiol. Int. 14:253.

17.

Lopez-Calderon

Ariznavarreta

Calderon

M.D.

Tresguerres

J.A.

and Gonzales-Quijano

M.I.

. 1989. Role of the adrenal cortex in chronic stress-induced inhibition of prolactin secretion in male rats. J. Endocrinol. 120:269.

18.

Vile

J.M.

and Strange

P.G.

. 1996. D2-like dopamine receptors are not detectable on human peripheral blood lymphocytes. Biol. Psychiatry 40:881.

19.

Neidhart

1997. Bromocriptine has little effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion. Biomed. Pharmacother. 51:118.

20.

Morikawa

Oseko

and Morikawa

. 1993. Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro. Clin. Exp. Immunol. 93:200.

21.

Morikawa

Oseko

and Morikawa

. 1994. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin. Exp. Immunol. 95:514.

22.

Dunn

A.J.

1990. Interleukin-1 as a stimulator of hormone secretion (PNEI REVIEW). Prog. Neuro Encocrin. Immunol. 3:26.

23.

Wilder

R.L.

1996. Hormones and autoimmunity: animals model of arthritis. In Baillier's Clinical Rheumatology Neuroendocrine Immune Mechanisms of Rheumatic Diseases. Chikanza

I.C.

, ed. Bailliere Tindal London, p. 259.

24.

de Kloet

E.R.

Rots

N.Y.

and Cools

A.R.

. 1996. Brain ñ corticosteroid hormone dialogue: slow and persistent (Review). Cell. Mol. Neurobiol. 3:345.

25.

Tilders

F.J.

and Schmidt

E.D.

. 1998. Interleukin-1 -induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness. Ann. N. Y. Acad. Sci. 840:65.

26.

Ohta

Yamane

Sohda

and Makino

. 1997. TAK-603 selectively suppresses Th1 -type cytokine production and inhibits the progression of adjuvant arthritis. Immunology 92:75.

27.

Roubenoff

Freeman

L.M.

Smith

D.E.

Abad

L.W.

Dinarello

C.A.

and Kehayias

J.J.

. 1997. Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum. 40:534.

28.

Nowak

Pietras

Antczak

Krol

and Piasecka

. 1993. Effect of bacterial lipopolysaccharide on the content of lipid peroxidation products in lungs and other organs of mice. Antonie Van Leeuwenhoek 63:77.

29.

Tanaka

Matsui

Murakami

Ishizuka

Sugiura

Kawashima

and Sugita

. 1998. Immunological abnormalities associated with the augmented nitric oxide synthesis in adjuvant-induced arthritis. Int. J. Immunopharmacol. 20:71.

30.

de Mello

S.B.

Novaes

G.S.

Laurindo

I.M.

Muscara

M.N.

Maciel

F.M.

and Cossermelli

. 1997. Nitric oxide synthase inhibitor influences prostaglandin and interleukin-1 production in experimental arthritic joints. Inflamm. Res. 46:72.